Leadless Pacemaker Tissue Engagement Verification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The challenge in implanting leadless cardiac pacemakers is securing them to intracardiac tissue effectively, as conventional methods lack verification of sufficient engagement of the fixation mechanism, which can lead to instability and inefficiency in cardiac pacing.

Innovation Solution

Incorporating a tissue engagement verification feature, such as radiopaque markers and anchoring members, to provide visual feedback during implantation, ensuring secure anchoring of the pacemaker to cardiac tissue through fluoroscopic observation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional fixation mechanisms are used to secure the leadless pacemaker to cardiac tissue, then the device can be implanted, but verification of sufficient engagement is lacking leading to potential instability

Engineering Contradiction:
Improveengagement verificationVSAvoidfixation mechanism
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent incorporates visual feedback features (radiopaque markers, movable indicators) that provide real-time information during implantation to confirm adequate tissue engagement of the fixation mechanism, allowing physicians to verify secure anchoring without adding complex verification systems

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces complex mechanical verification systems with visual/optical indicators that can be observed during fluoroscopy, substituting mechanical complexity with optical simplicity while maintaining engagement verification capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Stability of the object's composition

If no engagement verification is provided, then the device structure remains simple, but the stability and effectiveness of cardiac pacing is compromised

Engineering Contradiction:
Improvedevice stabilityVSAvoidverification feature
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent employs radiopaque markers and visual indicators that change position or appearance during implantation to signal engagement status, using visual contrast changes rather than complex mechanical or electronic verification systems to ensure device stability

Inventive Principle:
Principle #32Color changes

3Measurement precision

If radiopaque markers are added to provide visual feedback, then engagement verification is improved, but the device complexity increases

Engineering Contradiction:
Improveengagement detectionVSAvoiddevice structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses radiopaque markers as intermediary visual elements that translate the mechanical engagement state into observable signals during fluoroscopy, enabling precise engagement detection without requiring complex sensing or measurement systems within the device itself

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The verification feature ensures secure anchoring of the leadless cardiac pacemaker, enhancing the reliability and effectiveness of the implantation process by confirming tissue engagement, thereby stabilizing the device's position and ensuring proper cardiac pacing.

Implementation Method 1

a radiopaque marker movable relative to the housing and a radiopaque reference point stationary relative to the housing. Displacement of the radiopaque marker relative to the radiopaque reference point provides visual feedback of engagement of the tissue anchoring member in cardiac tissue

Methodology Applied
Scientific EffectRadiopacity: Absorption (EM radiation)

Data Source

PatentUS10080887B2Leadless cardiac pacing devices including tissue engagement verification
Publication Date: 2018.09.25 CARDIAC PACEMAKERS INC
  • US10080887B2 patent drawing
  • US10080887B2 patent drawing
  • US10080887B2 patent drawing

AI summary

An implantable leadless cardiac pacing device including a housing having a proximal end and a distal end, an electrode positioned proximate the distal end of the housing configured to be positioned adjacent cardiac tissue, and a tissue anchoring member extending from the distal end of the housing configured to secure the housing to cardiac tissue. The device further includes a tissue engagement verification feature configured to provide feedback upon engagement of the tissue anchoring member in cardiac tissue.